Effect of anti-Helicobacter pylori therapy on outcome of iron-deficiency anemia: a randomized, controlled study.
Article
in English
| IMSEAR
| ID: sea-65154
ABSTRACT
BACKGROUND:
Helicobacter pylori infection may play a role in iron-deficiency anemia.METHODS:
In 52 patients with iron-deficiency anemia, H. pylori status was determined using rapid urease test and histology. H. pylori -positive patients were randomly assigned to receive anti- H. pylori treatment either immediately (Group I) or after a delay of one month (Group II); in addition, all patients received oral ferrous sulfate for three months. Patients testing negative for H. pylori (Group III) received only oral ferrous sulfate. Hematological parameters were tested every month.RESULTS:
Of 52 patients, 32 (61.5%) had H. pylori infection. At the end of one month, median increase in hemoglobin level was lower in Group II than in Groups I and III (1.1 g/dL vs. 3.6 g/dL and 1.9 g/dL, respectively; p=0.025), as were that in serum iron (19 mcg/dL vs. 55.5 mcg/dL and 41 mcg/dL; p=0.019). During the second month, after H. pylori infection in Group II had been treated, median increase in hemoglobin in this group was comparable to those in Groups I and III (3.7 g/dL vs. 2.5 g/dL and 2.5 g/dL.CONCLUSION:
In patients with iron-deficiency anemia, presence of H. pylori infection is associated with a poorer response to oral iron therapy, which improves with treatment for H. pylori infection.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Female
/
Humans
/
Male
/
Ferrous Compounds
/
Case-Control Studies
/
Prospective Studies
/
Helicobacter pylori
/
Helicobacter Infections
/
Treatment Outcome
/
Anemia, Iron-Deficiency
Type of study:
Controlled clinical trial
/
Observational study
/
Risk factors
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS